Marcus P Kelly Selected Research

Hu3S193 monoclonal antibody

1/2009	Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.
4/2006	Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcus P Kelly Research Topics

Disease

13	Neoplasms (Cancer) 10/2021 - 10/2005
3	Breast Neoplasms (Breast Cancer) 01/2017 - 04/2006
2	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 01/2009
1	Lung Neoplasms (Lung Cancer) 10/2021
1	Cytokine Release Syndrome 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Testicular Neoplasms (Testicular Cancer) 01/2011
1	Residual Neoplasm 09/2007

Drug/Important Bio-Agent (IBA)

4	AntibodiesIBA 01/2021 - 05/2011
3	AntigensIBA 01/2021 - 01/2017
3	Prolactin Receptors (Prolactin Receptor)IBA 01/2018 - 01/2017
2	Immunoconjugates (Immunoconjugate)IBA 10/2021 - 01/2017
2	Tyrosine Kinase InhibitorsIBA 10/2021 - 10/2005
2	Bispecific AntibodiesIBA 01/2021 - 01/2019
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2019 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 05/2011 - 10/2005
2	Hu3S193 monoclonal antibodyIBA 01/2009 - 04/2006
2	Paclitaxel (Taxol)FDA LinkGeneric 09/2007 - 04/2006
1	cemiplimabIBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	theasinensin AIBA 01/2021
1	Blocking AntibodiesIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	CA-125 Antigen (CA 125 Antigen)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2018
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2018
1	epidermal growth factor receptor VIIIIBA 01/2018
1	Biological ProductsIBA 01/2018
1	IsotopesIBA 01/2018
1	Maytansine (Maitansine)IBA 01/2018
1	Ado-Trastuzumab EmtansineIBA 01/2017
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2017
1	LigandsIBA 05/2011
1	VaccinesIBA 01/2011
1	Cancer VaccinesIBA 01/2011
1	Mannose ReceptorIBA 01/2011
1	Docetaxel (Taxotere)FDA Link 01/2009
1	Lutetium-177IBA 01/2009
1	Single-Chain AntibodiesIBA 08/2008
1	Immunoglobulin G (IgG)IBA 08/2008
1	Radioisotopes (Radionuclides)IBA 09/2007
1	Phosphates (Orthophosphate)IBA 04/2006
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2005
1	Monoclonal AntibodiesIBA 10/2005

Therapy/Procedure

5	Therapeutics 10/2021 - 04/2006
5	Radioimmunotherapy 01/2009 - 10/2005
2	Drug Therapy (Chemotherapy) 01/2009 - 04/2006
1	Combination Drug Therapy (Combination Chemotherapy) 01/2019
1	Immunotherapy 01/2019